𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High dose toremifene for estrogen and progesterone receptor negative metastatic breast cancer: A phase II trial of the Cancer and Leukemia Group B (CALGB)

✍ Scribed by James J. Perry; Donald A. Berry; Raymond B. Weiss; Daniel M. Hayes; David B. Duggan; I. Craig Henderson

Publisher
Springer US
Year
1995
Tongue
English
Weight
442 KB
Volume
36
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of myelodysplastic syndrome wi
Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan : A Randomized Phase 2 Trial by the Cancer and Leukemia Group B (CALGB 19803)
✍ David L. Grinblatt; Daohai Yu; Vera Hars; James W. Vardiman; Bayard L. Powell; S πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 156 KB πŸ‘ 1 views

## Abstract ## BACKGROUD: The Cancer and Leukemia Group B evaluated oral topotecan administered at 2 schedules and doses for myelodysplastic syndrome (MDS). ## METHODS: Patients with previously untreated primary or therapy‐related MDS were eligible. Patients with refractory anemia (RA), RA with

Phase II study of high-dose fish oil cap
Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia : A Cancer and Leukemia Group B study
✍ C. Patrick Burns; Susan Halabi; Gerald Clamon; Ellen Kaplan; Raymond J. Hohl; Ja πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 133 KB πŸ‘ 3 views

## Abstract ## BACKGROUND The authors undertook a multiinstitutional Phase II cooperative group study to examine the potential of oral fish oil fatty acid supplements administered at high doses to slow weight loss and to improve quality of life in patients with malignancy‐related cachexia. ## MET

Methotrexate, vinblastine, doxorubicin,
Methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic breast cancer. A phase II trial of the hoosier oncology group
✍ Bruce J. Roth; George W. Sledge Jr; Stephen D. Williams; Steven C. Meyer; Rafat πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 490 KB πŸ‘ 2 views

Forty-six eligible patients with metastatic breast cancer (MBC) were treated with a combination of methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) as first-line chemotherapy. Of 44 patients evaluable for response, 28 (64%) had an objective response, including seven (16%) who had a comp